Wolverine Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-800	Closed	-$322K	–	1784
2024 Q4	$322K	Sell	800 -2,500	-76%	-$1.16M	﹤0.01%	944
2024 Q3	$1.53M	Sell	3,300 -20,600	-86%	-$9.9M	0.02%	582
2024 Q2	$11.2M	Buy	23,900 +3,300	+16%	+$1.43M	0.13%	178
2024 Q1	$8.61M	Buy	20,600 +20,500	+20,500%	+$8.67M	0.1%	207
2023 Q4	$40.7K	Buy	+100	New	+$36.9K	﹤0.01%	1233
2017 Q4	–	Sell	-66,200	Closed	-$10.1M	–	1610
2017 Q3	$10.1M	Sell	66,200 -33,800	-34%	-$5.09M	0.11%	159
2017 Q2	$12.9M	Buy	+100,000	New	+$12M	0.16%	122
2015 Q1	–	Sell	-233	Closed	-$1.52M	–	2223
2014 Q4	$1.52M	Sell	233 -1	-0.4%	-$113	0.03%	355
2014 Q3	$1.35M	Hold	234	–	–	0.03%	389
2014 Q2	$976K	Buy	234 +21	+10%	+$1.47K	0.02%	421
2014 Q1	$611K	Sell	213 -801	-79%	-$63.4K	0.01%	543
2013 Q4	$2.23M	Sell	1,014 -360	-26%	-$25.1K	0.04%	309
2013 Q3	$3.22M	Buy	1,374 +33	+2%	+$2.63K	0.07%	226
2013 Q2	$3.74M	Buy	+1,341	New	+$98.8K	0.1%	189